"AtaiBeckley’s MDMA-based drug for anxiety shows benefit in Phase IIa trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Analysts consider AtaiBeckley’s MDMA candidate a “high-risk, high-reward” bet after the drug demonstrated reductions in ...

Helus Pharma HELP shares are down on Thursday following the announcement of topline results from a Phase 2 signal detection study for HLP004, a potential treatment for generalized anxiety disorder ...

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...

WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...

Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, but doctors and researchers say the MAHA ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IF YOU HAVEN'T heard of gabapentin, listen up; it might be America’s new favorite chill pill. The news is ...

Researchers at São Paulo State University (UNESP) in Brazil have demonstrated in rats that a synthetic version of oxytocin can prevent anxiety-related behaviors caused by social stress. The study was ...

ORLANDO, FL - March 02, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational resource on ...

WASHINGTON — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in ...